For: | Park JY, Helm J, Coppola D, Kim D, Malafa M, Kim SJ. MicroRNAs in pancreatic ductal adenocarcinoma. World J Gastroenterol 2011; 17(7): 817-827 [PMID: 21412491 DOI: 10.3748/wjg.v17.i7.817] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i7/817.htm |
Number | Citing Articles |
1 |
Brittany Silverman, Jiaqi Shi. Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications. International Journal of Molecular Sciences 2016; 17(12): 2138 doi: 10.3390/ijms17122138
|
2 |
Rajesh Singh, James W. Lillard, Shailesh Singh. Epigenetic Advancements in Cancer. 2016; : 27 doi: 10.1007/978-3-319-24951-3_2
|
3 |
Heidelinde Sammallahti, Virinder Kaur Sarhadi, Arto Kokkola, Reza Ghanbari, Sama Rezasoltani, Hamid Asadzadeh Aghdaei, Pauli Puolakkainen, Sakari Knuutila. Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool. Biomolecules 2022; 12(5): 652 doi: 10.3390/biom12050652
|
4 |
Ibrahim Reyaz, Bilal Khan, Neha James, Hammad Azhar, Abdur Rehman, Muhammad Waqas Younas, Hamza Rashid, Faisal F Al-Shaikhly, Mazin M Almomani, Mohammed Khaleel I. KH. Almadhoun, Noor Abdullah Yahya, Syed Faqeer Hussain Bokhari, Ahsan Shehzad. Emerging Horizons in the Diagnosis of Pancreatic Cancer: The Role of Circulating microRNAs as Early Detection Biomarkers for Pancreatic Ductal Adenocarcinoma. Cureus 2024; doi: 10.7759/cureus.53023
|
5 |
Shiquan Li, Guoqiang Yan, Meng Yue, Zhenhua Kang, Lei Wang. MicroRNA‑766 inhibits the malignant biological behaviours of pancreatic ductal adenocarcinoma by directly targeting ETS1. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9770
|
6 |
Fiona O’Neill, Taylor-Jade Allen-Coyle, Sandra Roche, Justine Meiller, Neil T. Conlon, Niall Swan, Robert M. Straubinger, Justin Geoghegan, Ninfa L. Straubinger, Kevin Conlon, Ray McDermott, Finbarr O’Sullivan, Michael Henry, Paula Meleady, Gerard McVey, Robert O’Connor, Michael Moriarty, Martin Clynes. Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These Tumors. Life 2023; 13(3): 608 doi: 10.3390/life13030608
|
7 |
Eeva M. Laurila, Saana Sandström, Laura M. Rantanen, Reija Autio, Anne Kallioniemi. Both inhibition and enhanced expression of miR‐31 lead to reduced migration and invasion of pancreatic cancer cells. Genes, Chromosomes and Cancer 2012; 51(6): 557 doi: 10.1002/gcc.21941
|
8 |
Andee Weisbeck, Rick Jansen. Nutrients and the Pancreas: An Epigenetic Perspective. Nutrients 2017; 9(3): 283 doi: 10.3390/nu9030283
|
9 |
Yue Xue, Ahmad N. Abou Tayoun, Kristine M. Abo, J. Marc Pipas, Stuart R. Gordon, Timothy B. Gardner, Richard J. Barth, Arief A. Suriawinata, Gregory J. Tsongalis. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. Cancer Genetics 2013; 206(6): 217 doi: 10.1016/j.cancergen.2013.05.020
|
10 |
Evans Quilichini, Cécile Haumaitre. Implication of epigenetics in pancreas development and disease. Best Practice & Research Clinical Endocrinology & Metabolism 2015; 29(6): 883 doi: 10.1016/j.beem.2015.10.010
|
11 |
Irfana Muqbil, Fazlul H. Sarkar, Ramzi M. Mohammad, Asfar S. Azmi. Epigenetics and Cancer. 2013; : 1 doi: 10.1007/978-94-007-6612-9_1
|
12 |
Mike Mattie, Ashley Christensen, Mi Sook Chang, William Yeh, Suzanne Said, Yuriy Shostak, Linnette Capo, Alla Verlinsky, Zili An, Ingrid Joseph, Yi Zhang, Sathish Kumar-Ganesan, Karen Morrison, David Stover, Pia Challita-Eid. Molecular Characterization of Patient-Derived Human Pancreatic Tumor Xenograft Models for Preclinical and Translational Development of Cancer Therapeutics. Neoplasia 2013; 15(10): 1138 doi: 10.1593/neo.13922
|
13 |
Robert S. Edinger, Claudia Coronnello, Andrew J. Bodnar, William A. LaFramboise, Panayiotis V. Benos, Jacqueline Ho, John P. Johnson, Michael B. Butterworth. Aldosterone Regulates MicroRNAs in the Cortical Collecting Duct to Alter Sodium Transport. Journal of the American Society of Nephrology 2014; 25(11): 2445 doi: 10.1681/ASN.2013090931
|
14 |
Jinping Jia, Hemang Parikh, Wenming Xiao, Jason W Hoskins, Holger Pflicke, Xuelu Liu, Irene Collins, Weiyin Zhou, Zhaoming Wang, John Powell, Snorri S Thorgeirsson, Udo Rudloff, Gloria M Petersen, Laufey T Amundadottir. An integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancer. BMC Medical Genomics 2013; 6(1) doi: 10.1186/1755-8794-6-33
|
15 |
Lulu Farhana, Marcia I. Dawson, Farhan Murshed, Jayanta K. Das, Arun K. Rishi, Joseph A. Fontana, Jörg D. Hoheisel. Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R. PLoS ONE 2013; 8(5): e61015 doi: 10.1371/journal.pone.0061015
|
16 |
Javier Martinez-Useros, Mario Martin-Galan, Maria Florez-Cespedes, Jesus Garcia-Foncillas. Epigenetics of Most Aggressive Solid Tumors: Pathways, Targets and Treatments. Cancers 2021; 13(13): 3209 doi: 10.3390/cancers13133209
|
17 |
SHIDUO SONG, JIAN ZHOU, SONGBING HE, DONGMING ZHU, ZIXIANG ZHANG, HUA ZHAO, YI WANG, DECHUN LI. Expression levels of microRNA-375 in pancreatic cancer. Biomedical Reports 2013; 1(3): 393 doi: 10.3892/br.2013.88
|
18 |
Lulu Farhana, Marcia I Dawson, Joseph A Fontana. Down regulation of miR-202 modulates Mxd1 and Sin3A repressor complexes to induce apoptosis of pancreatic cancer cells. Cancer Biology & Therapy 2015; 16(1): 115 doi: 10.4161/15384047.2014.987070
|
19 |
Satyanarayana Rachagani, Muzafar A. Macha, Melanie S. Menning, Parama Dey, Priya Pai, Lynette M. Smith, Yin-Yuan Mo, Surinder K. Batra. Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model. Oncotarget 2015; 6(37): 40295 doi: 10.18632/oncotarget.5641
|
20 |
Neveen Abd El Moneim Hussein, Zenat A. El Kholy, Medhat M. Anwar, Mohamed A. Ahmad, Shaymaa M. Ahmad. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer. Journal of Cancer Research and Clinical Oncology 2017; 143(1): 83 doi: 10.1007/s00432-016-2248-7
|
21 |
Khanmi Kasomva, Arnab Sen, Michael Gabriel Paulraj, Stephen Sailo, Vandana Raphael, Kekungu-u Puro, Shiwoto Ruth Assumi, Savarimuthu Ignacimuthu. Roles of microRNA in prostate cancer cell metabolism. The International Journal of Biochemistry & Cell Biology 2018; 102: 109 doi: 10.1016/j.biocel.2018.07.003
|
22 |
Marta Herreros-Villanueva, Meritxel Gironella, Antoni Castells, Luis Bujanda. Molecular markers in pancreatic cancer diagnosis. Clinica Chimica Acta 2013; 418: 22 doi: 10.1016/j.cca.2012.12.025
|
23 |
Nicola Gaianigo, Davide Melisi, Carmine Carbone. EMT and Treatment Resistance in Pancreatic Cancer. Cancers 2017; 9(9): 122 doi: 10.3390/cancers9090122
|
24 |
Aristomenis-Dimitrios Tourvas, Constantinos C. Frangos. Towards an extension of the two-variable model of carcinogenesis through oncogenes and tumour suppressor genes. Medical Hypotheses 2011; 77(6): 956 doi: 10.1016/j.mehy.2011.08.017
|
25 |
Zhao-Chun Chi. Research status and prgoress of nonalcoholic fatty pancreatic disease. World Chinese Journal of Digestology 2020; 28(19): 933 doi: 10.11569/wcjd.v28.i19.933
|
26 |
CHUANLI REN, HUI CHEN, CHONGXU HAN, DAXIN WANG, DEYUAN FU. Increased plasma microRNA and CD133/CK18-positive cancer cells in the pleural fluid of a pancreatic cancer patient with liver and pleural metastases and correlation with chemoresistance. Oncology Letters 2012; 4(4): 691 doi: 10.3892/ol.2012.798
|
27 |
P.W. Stather, J.B. Wild, N. Sylvius, E. Choke, R.D. Sayers, M.J. Bown. MicroRNAs associated with the pathways involved in the pathogenesis of abdominal aortic aneurysms. Artery Research 2012; 7(1): 28 doi: 10.1016/j.artres.2012.09.005
|
28 |
RAMADEVI SUBRAMANI, LAXMAN GANGWANI, SUSHMITA BOSE NANDY, ARUNKUMAR ARUMUGAM, MUNMUN CHATTOPADHYAY, RAJKUMAR LAKSHMANASWAMY. Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review). International Journal of Oncology 2015; 47(4): 1203 doi: 10.3892/ijo.2015.3129
|